1. Factors Defining the Development of Severe Illness in Patients with COVID-19: A Retrospective Study.
- Author
-
Xiong YB, Tian YX, Ma Y, Yang W, Liu B, Ruan LG, Lu C, and Huang LQ
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Nomograms, Retrospective Studies, Severity of Illness Index, COVID-19 diagnosis, Risk Assessment
- Abstract
Objective: Early triage of patients with coronavirus disease 2019 (COVID-19) is pivotal in managing the disease. However, studies on the clinical risk score system of the risk factors for the development of severe disease are limited. Hence, we conducted a clinical risk score system for severe illness, which might optimize appropriate treatment strategies., Methods: We conducted a retrospective, single-center study at the JinYinTan Hospital from January 24, 2020 to March 31, 2020. We evaluated the demographic, clinical, and laboratory data and performed a 10-fold cross-validation to split the data into a training set and validation set. We then screened the prognostic factors for severe illness using the least absolute shrinkage and selection operator (LASSO) and logistic regression, and finally conducted a risk score to estimate the probability of severe illness in the training set. Data from the validation set were used to validate the score., Results: A total of 295 patients were included. From 49 potential risk factors, 3 variables were measured as the risk score: neutrophil to lymphocyte ratio ( OR , 1.27; 95% CI , 1.15-1.39), albumin ( OR , 0.76; 95% CI , 0.70-0.83), and chest computed tomography abnormalities ( OR , 2.01; 95% CI , 1.41-2.86) and the AUC of the validation cohort was 0.822 (95% CI , 0.7667-0.8776)., Conclusion: This report may help define the potential of developing severe illness in patients with COVID-19 at an early stage, which might be related to the neutrophil to lymphocyte ratio, albumin, and chest computed tomography abnormalities., (Copyright © 2021 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF